Late follow-up of occlusion of the patent ductus arteriosus with the Rashkind device with emphasis on long-term efficacy and risk for infections

Am J Cardiol. 2001 Sep 1;88(5):586-8. doi: 10.1016/s0002-9149(01)01749-0.
No abstract available

MeSH terms

  • Blood Vessel Prosthesis / adverse effects*
  • Blood Vessel Prosthesis Implantation / methods
  • Cardiac Catheterization / methods
  • Confidence Intervals
  • Ductus Arteriosus, Patent / diagnostic imaging
  • Ductus Arteriosus, Patent / therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Probability
  • Proportional Hazards Models
  • Prosthesis Failure
  • Prosthesis-Related Infections / epidemiology
  • Prosthesis-Related Infections / etiology
  • Prosthesis-Related Infections / prevention & control*
  • Retrospective Studies
  • Risk Assessment
  • Time Factors
  • Treatment Outcome
  • Ultrasonography, Doppler